Havana, Cuba

Carlos Antonio Cano

This inventor holds 1 USPTO granted patent. Top assignee: Centro De Ingenieria Genetica Y Biotecnologia. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Antonio Cano. Retrieved from https://idiyas.com/inventor/carlos-antonio-cano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carlos Antonio Cano: Innovator in Genetic Engineering

Introduction

Carlos Antonio Cano is a prominent inventor based in Havana, Cuba. He has made significant contributions to the field of genetic engineering, particularly in the expression of heterologous antigens. His work has implications for vaccine development and biotechnology.

Latest Patents

Carlos holds a patent for a "System for the expression of heterologous antigens as fusion proteins." This innovative approach enhances the production of proteins that can be used in various biotechnological applications. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Carlos is affiliated with the Centro de Ingeniería Genética y Biotecnología, a leading research institution in Cuba. His role at this center allows him to engage in cutting-edge research and development in genetic engineering. His contributions have been vital in advancing the field within the region.

Collaborations

Throughout his career, Carlos has worked alongside notable colleagues, including Maria De Angulo and Alejandro Miguel Dunn. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Carlos Antonio Cano is a key figure in the field of genetic engineering, with a focus on the expression of heterologous antigens. His work at the Centro de Ingeniería Genética y Biotecnología and his patent contributions highlight his commitment to advancing biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…